Literature DB >> 9180655

Validation of pharmacy records in drug exposure assessment.

H S Lau1, A de Boer, K S Beuning, A Porsius.   

Abstract

The validity of drug exposure measurement based on pharmacy records was investigated taking into account completeness of data, drug compliance, and different methods of drug exposure measurement in pharmacy records. Data on prescription drug use were collected from home inventories and community pharmacies in a survey on drug use and compliance in 115 elderly people. To compare drug exposure in pharmacy records with exposure in the home inventory, three different methods for exposure measurement in pharmacy records were used. Two employed a fixed time window of 30 and 90 days, respectively, and the third method was based on the calculated duration of use of a prescription ("legend time"). Drug exposure in the home inventory was taken as the gold standard and sensitivity, specificity, and positive predictive values of the different methods were calculated for the most frequently used drugs and drug categories. The specificity and positive predictive value of all three methods was generally high (0.93-1.00 and 0.67-1.00, respectively). The 90-day fixed method and the legend time method generally showed high sensitivity (range: 0.67-1.00 and 0.63-0.83, respectively) for drugs that were used on a chronic basis, while the 30-day fixed method had poor sensitivity (range: 0.29-0.69). Drugs that were used according to the home inventory but not according to the pharmacy records methods could be almost completely retrieved in the pharmacy records of a one-year period showing that these records were virtually complete with regard to prescription drugs. We conclude that computerized pharmacy records can be a reliable source of the true drug exposure as estimated in a home inventory, when adequate attention is paid to the definition of the exposure time-window and when these records are comprehensive with regard to prescription drugs.

Entities:  

Mesh:

Year:  1997        PMID: 9180655     DOI: 10.1016/s0895-4356(97)00040-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  122 in total

1.  How do we best detect toxic effects of drugs taken during pregnancy? A EuroMap paper.

Authors:  Jørn Olsen; Andrew Czeizel; Henrik Toft Sørensen; Gunnar Lauge Nielsen; Lolkje T W de Jong van den Berg; Lorentz M Irgens; Charlotte Olesen; Lars Pedersen; Helle Larsen; Rolv T Lie; Corinne S de Vries; Ulf Bergman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent.

Authors:  Gregory A Roth; Nancy E Morden; Weiping Zhou; David J Malenka; Jonathan Skinner
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

3.  Limited adherence to safety instructions in drug leaflets.

Authors:  H J Derijks; G H P De Koning; A K Mantel-Teeuwisse; A C G Egberts
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

4.  Anti-asthmatic drugs and dosage forms in children: a cross-sectional study.

Authors:  Eric Schirm; Hilde Tobi; Henkjan Gebben; Lolkje T W de Jong-van den Berg
Journal:  Pharm World Sci       Date:  2002-08

5.  Psychotropic medication claims among religious clergy.

Authors:  Steven M Frenk; Sarah A Mustillo; Steven L Foy; Whitney D Arroyave; Elizabeth G Hooten; Kari H Lauderback; Keith G Meador
Journal:  Psychiatr Q       Date:  2013-03

6.  Understanding Adherence and Prescription Patterns Using Large-Scale Claims Data.

Authors:  Margrét V Bjarnadóttir; Sana Malik; Eberechukwu Onukwugha; Tanisha Gooden; Catherine Plaisant
Journal:  Pharmacoeconomics       Date:  2016-02       Impact factor: 4.981

7.  The use of nationwide on-line prescription records improves the drug history in hospitalized patients.

Authors:  Bente Glintborg; Henrik E Poulsen; Kim P Dalhoff
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

8.  Direct oral anticoagulant and antiplatelet combination therapy: Hemorrhagic events in coronary artery stent recipients.

Authors:  Kimon Bekelis; Chiang-Hua Chang; David Malenka; Nancy E Morden
Journal:  J Clin Neurosci       Date:  2018-02-01       Impact factor: 1.961

9.  Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use.

Authors:  Nancy S Green; Deepa Manwani; Mahvish Qureshi; Karen Ireland; Arpan Sinha; Arlene M Smaldone
Journal:  Pediatr Blood Cancer       Date:  2016-08-30       Impact factor: 3.167

10.  The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care.

Authors:  Michael Due Larsen; Mette Schou; Anja Sparre Kristiansen; Jesper Hallas
Journal:  Eur J Clin Pharmacol       Date:  2014-04-27       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.